Latest Government Support News

Western Mines Group has completed diamond drill hole MTD030 at its Mulga Tank Project, intersecting extensive olivine cumulate ultramafic rock with multiple intervals of visible nickel sulphide mineralisation, including high-tenor blebs confirmed by spot pXRF readings up to 41.3% nickel. This confirms a dynamic komatiite system and reinforces the project's large-scale potential.

Peak Rare Earths has secured an increased cash offer from Shenghe Resources, valuing the company at A$195 million. An independent expert confirms the revised scheme remains fair and reasonable for shareholders.

ALCORE, ABx Group’s subsidiary, has secured government approval for overseas R&D activities and is pursuing a $5 million grant to accelerate its clean fluorine chemical technology commercialisation.

Thor Energy has signed a term sheet with DISA Technologies to explore processing abandoned uranium waste dumps in Colorado, aiming to generate revenue without upfront costs using innovative HPSA technology.

Acrux Limited has received a $3.04 million R&D Tax Incentive rebate for FY25 and fully repaid its short-term funding facility, underscoring its commitment to Australian pharmaceutical innovation.

Tali Resources has completed its initial reverse circulation drilling program at the West Arunta Project, with assay results expected in the December quarter. The company is advancing further exploration activities backed by government incentives.

Dateline Resources has secured $25 million in an institutional placement to accelerate exploration and development at its Colosseum Gold-REE Project in California, backed by strong U.S. government support and promising new targets.

Tamboran Resources Corporation advances its Beetaloo Basin gas project with record well flow rates and strategic partnerships, targeting initial production by mid-2026. The company is also progressing a farmout for Phase 2 acreage amid rising East Coast gas demand.

Island Pharmaceuticals has formally requested a Type C meeting with the US FDA to discuss accelerating approval of its antiviral Galidesivir for Marburg virus using the Animal Rule pathway.

Xamble Group Limited reported a sharp 39% revenue decline and a doubling of losses in H1 FY2025, driven by strategic exit from Taiwan and increased technology spending. Despite financial setbacks, operational metrics show strong user and client growth, underpinning the company’s Southeast Asia-focused transformation.

Bhagwan Marine Limited has reported record financial results for FY25, driven by strong growth across its core marine services and new sectors. The company also declared its inaugural fully franked dividend, signaling confidence in its strategic direction.

Civmec Limited reported a 21.6% drop in revenue and a 34% fall in net profit for FY2025, reflecting the impact of completed contracts. Despite this, the company maintained steady margins and increased its cash reserves, signaling resilience and ongoing growth potential.